ALEJO PARELLADA: Open Payments
NPI 1417070442 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,509 in 147 payments from 13 companies in 2025. Trend: 2023 $4,017 · 2024 $4,636 · 2025 $4,509
Food & beverage: $4,407Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 23 | $958 |
| E.R. Squibb & Sons, L.L.C. | 16 | $828 |
| ABBVIE INC. | 36 | $756 |
| Otsuka America Pharmaceutical, Inc. | 17 | $470 |
| Axsome Therapeutics, Inc. | 10 | $431 |
| Alkermes, Inc. | 15 | $401 |
| Lundbeck LLC | 22 | $355 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $114 |
| Vanda Pharmaceuticals Inc. | 3 | $100 |
| Braeburn Inc. | 1 | $30 |
Products named: COBENFY, UZEDY, VRAYLAR, REXULTI, ARISTADA, Auvelity, Sunosi, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
